Kazuhisa Hagiwara

Hirosaki University

Papers

1

Total Citations

13

H-Index

1

About

Kazuhisa Hagiwara is a urologic surgeon and researcher whose work focuses on advancing surgical and oncological outcomes for high-risk prostate cancer. His key research areas include neoadjuvant chemohormonal therapy, robot-assisted radical prostatectomy, and minimally invasive surgical techniques. Hagiwara’s major contribution lies in systematically comparing perioperative and oncological outcomes between robot-assisted and minimum incision endoscopic radical prostatectomy following neoadjuvant therapy, providing critical evidence that helps tailor surgical approaches for patients with aggressive disease. His most cited work, a 2018 study on this topic, has garnered 13 citations, reflecting its relevance in the evolving landscape of prostate cancer management. By demonstrating the feasibility and safety of these combined strategies at a single institution, Hagiwara has helped bridge the gap between systemic therapy and precision surgery. His research underscores a commitment to improving both cancer control and quality of life, offering valuable insights for clinicians and researchers seeking to optimize multimodal treatment pathways.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution
13 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Hirosaki University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago